Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nektar Therapeutics Gross Margin 2010-2025 | NKTR

Current and historical gross margin for Nektar Therapeutics (NKTR) over the last 10 years. The current gross profit margin for Nektar Therapeutics as of March 31, 2025 is %.
  
Nektar Therapeutics Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $0.09B $0.07B 75.58%
2024-12-31 $0.10B $0.07B 69.39%
2024-09-30 $0.09B $0.06B 68.82%
2024-06-30 $0.09B $0.06B 60.22%
2024-03-31 $0.09B $0.06B 62.22%
2023-12-31 $0.09B $0.06B 64.44%
2023-09-30 $0.09B $0.06B 64.77%
2023-06-30 $0.09B $0.06B 72.73%
2023-03-31 $0.09B $0.07B 73.33%
2022-12-31 $0.09B $0.07B 76.34%
2022-09-30 $0.10B $0.07B 77.08%
2022-06-30 $0.10B $0.08B 77.32%
2022-03-31 $0.10B $0.08B 77.67%
2021-12-31 $0.10B $0.08B 76.47%
2021-09-30 $0.10B $0.08B 78.00%
2021-06-30 $0.11B $0.08B 78.10%
2021-03-31 $0.13B $0.10B 82.54%
2020-12-31 $0.15B $0.13B 86.93%
2020-09-30 $0.16B $0.14B 86.59%
2020-06-30 $0.16B $0.14B 87.12%
2020-03-31 $0.14B $0.12B 85.40%
2019-12-31 $0.11B $0.09B 81.58%
2019-09-30 $0.12B $0.10B 80.83%
2019-06-30 $0.12B $0.10B 80.67%
2019-03-31 $1.18B $1.16B 97.97%
2018-12-31 $1.19B $1.17B 97.82%
2018-09-30 $1.25B $1.22B 97.84%
2018-06-30 $1.37B $1.35B 97.96%
2018-03-31 $0.32B $0.29B 90.34%
2017-12-31 $0.31B $0.28B 90.26%
2017-09-30 $0.25B $0.22B 89.20%
2017-06-30 $0.13B $0.11B 78.95%
2017-03-31 $0.13B $0.10B 79.39%
2016-12-31 $0.17B $0.14B 81.82%
2016-09-30 $0.17B $0.14B 80.84%
2016-06-30 $0.19B $0.16B 83.25%
2016-03-31 $0.18B $0.15B 80.66%
2015-12-31 $0.23B $0.20B 84.85%
2015-09-30 $0.21B $0.18B 83.96%
2015-06-30 $0.29B $0.25B 87.37%
2015-03-31 $0.29B $0.26B 89.35%
2014-12-31 $0.20B $0.17B 85.15%
2014-09-30 $0.21B $0.18B 84.98%
2014-06-30 $0.14B $0.11B 74.47%
2014-03-31 $0.15B $0.11B 76.03%
2013-12-31 $0.15B $0.11B 73.83%
2013-09-30 $0.14B $0.10B 73.38%
2013-06-30 $0.10B $0.07B 67.71%
2013-03-31 $0.09B $0.05B 60.47%
2012-12-31 $0.08B $0.05B 61.73%
2012-09-30 $0.08B $0.05B 60.53%
2012-06-30 $0.09B $0.06B 67.06%
2012-03-31 $0.08B $0.05B 64.10%
2011-12-31 $0.07B $0.05B 69.01%
2011-09-30 $0.10B $0.07B 74.00%
2011-06-30 $0.11B $0.08B 75.68%
2011-03-31 $0.14B $0.11B 82.48%
2010-12-31 $0.16B $0.13B 84.28%
2010-09-30 $0.15B $0.13B 84.31%
2010-06-30 $0.13B $0.10B 80.80%
2010-03-31 $0.10B $0.07B 69.47%
2009-12-31 $0.07B $0.04B 56.94%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.108B $0.098B
Nektar Therapeutics is a biopharmaceutical company, focused on the development of treatments utilizing its PEGylation and advanced polymer conjugate technology platforms. Nektar primarily finances its operations with funds from licensing, collaboration and manufacturing agreements. It has collaboration deals with companies namely AstraZeneca, Pfizer, Roche, Amgen, Bristol-Myers and Eli Lilly among others. The company's most lucrative deal is with Bristol-Myers, which provided the company with significant cash resources to support progress of its pipeline and share development costs for its lead candidate, bempegaldesleukin. Nektar recognizes product sales from its manufacturing and supply agreements with several pharma companies related to products developed using its PEGylation platform. The company also earns royalty payments from the sales of products using its technology platforms. Amgen's neutropenia drug, Neulasta is one of the drugs developed using Nektar's PEGylation platform.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.131B 31.18
Zoetis (ZTS) United States $71.977B 26.85
Takeda Pharmaceutical (TAK) Japan $47.379B 9.42
Daiichi Sankyo, - (DSNKY) Japan $45.180B 23.16
BeOne Medicines - (ONC) Cayman Islands $27.838B 0.00
Sandoz Group AG (SDZNY) Switzerland $22.876B 0.00
Merck (MKKGY) Germany $16.572B 12.14
Summit Therapeutics (SMMT) United States $14.742B 0.00
Shionogi (SGIOY) Japan $14.496B 14.52
United Therapeutics (UTHR) United States $12.940B 11.45
Neurocrine Biosciences (NBIX) United States $12.359B 42.33
Orion OYJ (ORINY) Finland $10.283B 27.81
IPSEN (IPSEY) France $10.093B 0.00
Corcept Therapeutics (CORT) United States $7.619B 61.94
Stevanato Group S.p.A (STVN) Italy $7.299B 44.63
Madrigal Pharmaceuticals (MDGL) United States $6.208B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.099B 0.00
Ionis Pharmaceuticals (IONS) United States $5.754B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $3.911B 0.00
Hypermarcas (HYPMY) Brazil $3.177B 20.90
Crinetics Pharmaceuticals (CRNX) United States $2.888B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.832B 9.92
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.476B 13.39
BioCryst Pharmaceuticals (BCRX) United States $2.086B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.076B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.967B 0.00
Indivior (INDV) United States $1.899B 8.05
Centessa Pharmaceuticals (CNTA) United Kingdom $1.683B 0.00
ARS Pharmaceuticals (SPRY) United States $1.456B 0.00
Evotec AG (EVO) Germany $1.424B 0.00
Ocular Therapeutix (OCUL) United States $1.322B 0.00
Guardian Pharmacy Services (GRDN) United States $1.245B 0.00
Dyne Therapeutics (DYN) United States $1.234B 0.00
Harrow (HROW) United States $1.116B 0.00
Enliven Therapeutics (ELVN) United States $1.070B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.069B 21.38
Verve Therapeutics (VERV) United States $1.014B 0.00
Collegium Pharmaceutical (COLL) United States $0.946B 5.10
Akebia Therapeutics (AKBA) United States $0.919B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.906B 0.00
Ardelyx (ARDX) United States $0.849B 0.00
Elite Pharmaceuticals (ELTP) United States $0.828B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.710B 0.00
KalVista Pharmaceuticals (KALV) United States $0.604B 0.00
Xencor (XNCR) United States $0.591B 0.00
Regulus Therapeutics (RGLS) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.567B 12.33
Altimmune (ALT) United States $0.559B 0.00
Theravance Biopharma (TBPH) United States $0.530B 0.00
Relay Therapeutics (RLAY) United States $0.525B 0.00
Bioventus (BVS) United States $0.522B 13.23
AleAnna (ANNA) United States $0.491B 0.00
Zevra Therapeutics (ZVRA) United States $0.482B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.475B 0.00
Tourmaline Bio (TRML) United States $0.467B 0.00
Siga Technologies (SIGA) United States $0.450B 9.40
Oruka Therapeutics (ORKA) United States $0.448B 0.00
Organogenesis (ORGO) United States $0.397B 0.00
Savara (SVRA) United States $0.353B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.342B 9.26
Liminatus Pharma (LIMN) United States $0.333B 0.00
Aquestive Therapeutics (AQST) United States $0.333B 0.00
Heron Therapeutics (HRTX) United States $0.298B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.22
Tonix Pharmaceuticals Holding (TNXP) United States $0.257B 0.00
ProKidney (PROK) United States $0.251B 0.00
Nanobiotix S.A (NBTX) France $0.217B 0.00
Esperion Therapeutics (ESPR) United States $0.216B 0.00
MediWound (MDWD) Israel $0.214B 0.00
OmniAb (OABI) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.204B 0.00
4D Molecular Therapeutics (FDMT) United States $0.192B 0.00
Aldeyra Therapeutics (ALDX) United States $0.185B 0.00
Larimar Therapeutics (LRMR) United States $0.172B 0.00
Aclaris Therapeutics (ACRS) United States $0.152B 0.00
Galectin Therapeutics (GALT) United States $0.151B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.151B 0.00
Journey Medical (DERM) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Avita Medical (RCEL) United States $0.138B 0.00
VAXART, INC (VXRT) United States $0.136B 0.00
Lexeo Therapeutics (LXEO) United States $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.129B 0.00
Korro Bio (KRRO) United States $0.118B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Cardiol Therapeutics (CRDL) Canada $0.113B 0.00
Champions Oncology (CSBR) United States $0.111B 18.30
Achieve Life Sciences (ACHV) Canada $0.103B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
Wellgistics Health (WGRX) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.087B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.081B 60.00
Surrozen (SRZN) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Telomir Pharmaceuticals (TELO) United States $0.055B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.050B 0.00
Avalo Therapeutics (AVTX) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.034B 0.00
Jupiter Neurosciences (JUNS) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
FibroGen (FGEN) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.24
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
CERo Therapeutics Holdings (CERO) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00